- Generic name
- Ondansetron
- Strength
- 8 mg
- Dosage form
- Orodispersible Tablet
- Manufactured by
- Biopharma Ltd.
Onstar ODT 8 Orodispersible Tablet
About Onstar ODT 8 Orodispersible Tablet
The orodispersible tablet Onstar ODT 8 contains Ondansetron and is made by Biopharma Ltd. It is not a general-purpose anti-emetic for all types of nausea.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Onstar ODT 8 Orodispersible Tablet?
Onstar ODT 8 8 mg orodispersible tablet is a medicine made by Biopharma Ltd. This medicine is commonly prescribed for people receiving cancer chemotherapy or radiotherapy, and for preventing nausea and vomiting after operations. It contains Ondansetron, which belongs to a group of drugs called serotonin receptor antagonists. Whether it suits a particular person, and how it should be taken, is decided by the doctor.
Uses of Onstar ODT 8
It is not a general-purpose anti-emetic for all types of nausea. It is not a general anti-nausea medicine for all causes; your doctor will decide if it is appropriate for your situation. Onstar ODT 8 orodispersible tablet is used to help prevent nausea and vomiting caused by emetogenic cancer chemotherapy, including repeat courses of treatment. The doctor decides whether it is suitable and how it should be used.
How to use Onstar ODT 8
Onstar ODT 8 orodispersible tablets should be taken exactly as the doctor prescribes. Onstar ODT 8 is taken by mouth. Swallow the orodispersible tablet with water. It is not for self-administration. The doctor will decide the exact dose, how often to take it, and how long the course should last, based on the reason it is being used and the patient's age and weight.
Side effects of Onstar ODT 8
Common side effects include headache, constipation, and diarrhea. Rarely, serious reactions such as allergic reactions, breathing difficulty, fast heartbeat or chest pain have been reported. Rash has been reported in some patients receiving Ondansetron for chemotherapy-induced nausea and vomiting. Tell your doctor if you have any side effect that worries you or does not go away. Tell your doctor if you notice any side effects.
Safety and precautions
Do not take Onstar ODT 8 if you are allergic to Ondansetron or any of its ingredients, or if you are taking apomorphine. Anyone with heart, liver or other health problems should check with the doctor first. Pregnancy and breastfeeding should be discussed with the doctor first, as should liver problems and other medicines you take. Tell your doctor about allergies to similar anti-emetic medicines.
Frequently asked questions
What does Onstar ODT 8 treat?
It is not a general-purpose anti-emetic for all types of nausea. It is not a general anti-nausea medicine for all causes; your doctor will decide if it is appropriate for your situation.
How should I take Onstar ODT 8?
Onstar ODT 8 orodispersible tablets should be taken exactly as the doctor prescribes. Onstar ODT 8 is taken by mouth.
Can Onstar ODT 8 cause side effects?
Common side effects include headache, constipation, and diarrhea. Rarely, serious reactions such as allergic reactions, breathing difficulty, fast heartbeat or chest pain have been reported.
Can I use Onstar ODT 8 in pregnancy or while breastfeeding?
Do not take Onstar ODT 8 if you are allergic to Ondansetron or any of its ingredients, or if you are taking apomorphine. Anyone with heart, liver or other health problems should check with the doctor first.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.